Read the Bioanalysis Zone team’s top five take away messages from the 12th EBF Open Symposium, from automation to patient-centric sampling in this conference report.
The AAPS PharmSci360 conference was held in San Antonio (TX, USA) from 3–6 November 2019. The Bioanalysis and Bioanalysis Zone team both attended and, in this report, share their key highlights from the conference.
In a pilot study, researchers from the School of Medicine at the University of Nottingham (UK), report the use of protein microarrays to rapidly screen blood samples for the presence of autoantibodies associated with breast cancer.
Researchers report a diagnostic tool that analyses the risk factors for preterm birth, results indicated approximately 10% of women from 340 vaginal fluid samples analyzed were at risk. This diagnostic tool could reduce the likelihood of premature delivery.
Scientists from the University of Utah (UT, USA) report a novel miRNA biomarker -based strategy that could improve melanoma diagnosis.
A recent study reports a new biomarker panel, comprised of 28 physical and molecule measures, that could successfully confirm the diagnosis of warzone-related post-traumatic stress disorder (PTSD) with 77% accuracy.
In a new study, researchers from Osaka University (Japan) have demonstrated that measuring methylation of microRNA could accurately distinguish individuals with early pancreatic cancer from healthy controls.
Researchers have discovered unique populations of neurons in the spinal cords of patients who died of amyotrophic lateral sclerosis that could be utilized as potential drug targets.
A multiplex HRMS assay for quantifying selected human plasma bile acids as candidate OATP biomarkers
This preliminary communication from Bioanalysis discusses the application of selected bile acids in plasma as endogenous probes for assessing drug–drug interactions involving hepatic drug transporters such as the organic anion-transporting polypeptides.
In this interview, Hanna Ritzén (Mercodia; Uppsala, Sweden) provides an insight into her recent article on classification of commercial LBA kits for biomarkers, and why this area of bioanalysis is important.